Inactive

Office of the Commissioner | Office of Clinical Policy and Programs (OCPP) would use its access to CQ to monitor new and pending issues related to the Common Rule and human subject protection and/or o... Office of the Commissioner | Office of Clinical Policy and Programs (OCPP) would use its access to CQ to monitor new and pending issues related to the Common Rule and human subject protection and/or other issues that require staff expertise (e.g., participation on FDA workgroups that review legislation or participation on issues related to COVID-19). OCPP, for example, is tasked with implementing two provisions of the 21st Century Cures Act to include modifications to FDA’s human subject protection regulations; having timely access to any new developments on the 21st Century Cures Act or related issues would be beneficial to OCPP’s mission. The Government intends to award a firm-fixed price purchase order resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantegous to the Government, price and other factors considered.